TCA
Trifecta Capital Advisors’s Boston Scientific BSX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.99M | Buy |
46,411
+3,010
| +7% | +$323K | 0.83% | 39 |
|
|
2025
Q1 | $4.38M | Buy |
43,401
+4,456
| +11% | +$450K | 0.92% | 38 |
|
|
2024
Q4 | $3.48M | Buy |
38,945
+38,895
| +77,790% | +$3.47M | 0.69% | 41 |
|
|
2024
Q3 | $4.19K | Hold |
50
| – | – | ﹤0.01% | 244 |
|
|
2024
Q2 | $3.85K | Hold |
50
| – | – | ﹤0.01% | 256 |
|
|
2024
Q1 | $3.43K | Hold |
50
| – | – | ﹤0.01% | 255 |
|
|
2023
Q4 | $2.89K | Hold |
50
| – | – | ﹤0.01% | 289 |
|
|
2023
Q3 | $2.64K | Hold |
50
| – | – | ﹤0.01% | 278 |
|
|
2023
Q2 | $2.71K | Hold |
50
| – | – | ﹤0.01% | 269 |
|
|
2023
Q1 | $2.5K | Hold |
50
| – | – | ﹤0.01% | 283 |
|
|
2022
Q4 | $2.31K | Buy |
+50
| New | +$2.31K | ﹤0.01% | 283 |
|